# DCAT

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/dcat
Canonical HTML page: https://gethealthbrief.com/entity/dcat

## Timeline

- **2026-03-09**: DCAT Week 2026 — LOTTE Biologics engages in high-level partnership talks in New York City.
- **2025-12-01**: ADC Expansion — Completion of specialized ADC manufacturing lines at the Syracuse facility.
- **2024-03-15**: Songdo Groundbreaking — Construction begins on the first Mega Plant in Songdo, South Korea.
- **2023-01-01**: Syracuse Acquisition — LOTTE Biologics completes the acquisition of the Syracuse, NY plant from Bristol Myers Squibb.

## Recent coverage (1 stories)

### LOTTE Biologics Targets Global Expansion at DCAT Week 2026
2026-03-09 07:39:53 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

LOTTE Biologics is attending DCAT Week 2026 in New York to secure high-value global partnerships and solidify its position in the CDMO market. This move underscores the company's aggressive strategy to leverage its U.S. manufacturing footprint and upcoming South Korean capacity.
Full story: https://gethealthbrief.com/story/lotte-biologics-dcat-week-2026-global-partnerships

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.